Bispecific heterodimeric fusion proteins containing IL-15-IL-15Rα Fc-fusion proteins and PD-1 antibody fragments

Bi-specific monovalent diabodies that are capable of binding to gpA33 and CD3, and uses thereof

Antibodies targeting G-protein coupled receptor and methods of use

Anti-IL-33 antibodies and uses thereof for disease treatment

IL-17A binding proteins

Sensor systems for target ligands and uses thereof

Bispecific multivalent fusion proteins

IL15/IL15Rα heterodimeric Fc-fusion proteins

Drug conjugates comprising antibodies against claudin 18.2

Antibody-coupled cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptors

Anti-CD3 antibodies and methods of use

ANTAGONISTS OF IL-6 TO PREVENT OR TREAT CACHEXIA, WEAKNESS, FATIGUE, AND/OR FEVER

Combination of anti-KIR and anti-CTLA-4 antibodies to treat cancer

Immune complex

T CELL RETARGETING HETERO-DIMERIC IMMUNOGLOBULINS

Methods for phrasing epigenetic modifications of genomes

Anti-MUC16 antibodies and uses thereof

Polynucleotides encoding anti-Notch1 NRR antibody polypeptides

Modulators of ROR1-ROR2 binding

Bispecific antigen-binding molecules that bind MUC16 and CD3, and compositions thereof

HUMANIZED ANTIBODY OR FRAGMENT THEREOF SPECIFIC FOR CD3

Antibodies to human programmed death receptor PD-1

Anti-PD1 antibodies and their use as therapeutics and diagnostics

DKK1 antibodies and methods of use

Monoclonal antibodies that neutralize anthrax toxins

Inhibitors and their uses

Immune conjugate having dendron conjugated to antibody and use thereof

Therapy for metastatic urothelial cancer with the antibody-drug conjugate, sacituzumab govitecan (IMMU-132)

METHODS OF ASSESSING GFAP STATUS IN PATIENT SAMPLES

Nucleic acids encoding bispecific antibodies binding to beta-Klotho and fibroblast growth factor receptor 1

Anti-MCAM antibodies and associated methods of use

Antibodies against signal-regulatory protein alpha and methods of use

Antibodies against human NKG2D and uses thereof

Antibodies that bind and block triggering receptor expressed on myeloid cells-1 (TREM-1)

Antibodies to amyloid beta

ANTIBODY DIRECTED AGAINST IMMUNOGLOBULIN-BINDING PROTEINS OF S. AUREUS

Antibodies that bind Zika virus envelope protein and uses thereof

Monovalent, bivalent and trivalent anti human respiratory syncytial virus (HRSV) nanobody constructs for the prevention and/or treatment of respiratory tract infections

Antibodies that potently neutralize rabies virus and other lyssaviruses and uses thereof

Anti-STEAP2 antibody drug conjugates, and compositions and uses thereof

CD5 chimeric antigen receptor for adoptive T cell therapy

Method of determining the presence and/or amount of target molecules

Compositions and methods for treating cocaine-related disorders

HUMANIZED ANTI-FACTOR D ANTIBODIES AND USES THEREOF

CHIMERIC RABBIT/HUMAN ROR1 ANTIBODIES

Humanized Anti-CXCR5 Antibodies, Derivatives Thereof and Their Use

FGFR1 AGONISTS AND METHODS OF USE

Anti-FLT-1 antibodies in treating bronchopulmonary dysplasia

RGMa binding protein and use thereof

Erythrocyte-binding therapeutics

POLYPEPTIDE COMPRISING AN IMMUNOGLOBULIN CHAIN VARIABLE DOMAIN WHICH BINDS TO CLOSTRIDIUM DIFFICILE TOXIN A

TREATMENT WITH ANTI-EFNA4 ANTIBODY-DRUG CONJUGATES

Anti-sclerostin antibody, antigen binding fragment and medical use thereof

Humanized influenza monoclonal antibodies and methods of use thereof

De novo engineering of site-specific molecules by tethering

Bispecific antibodies that bind to CD38 and CD3

DUAL TARGETING

ANTI-PTK7 ANTIBODY-DRUG CONJUGATES

Anti-TROP2 antibody-drug conjugate

Bi-specific monovalent diabodies that are capable of binding CD123 and CD3, and uses thereof

Anti-CSF1R antibody and anti PD-1 antibody combination therapy for cancer

Antagonist antibodies to human prolactin receptor (PRLR)

Antibodies directed against interleukin 36 receptor (IL-36R)

AFFINITY MATURED ANTI-CCR4 HUMANIZED MONOCLONAL ANTIBODIES AND METHODS OF USE

Monoclonal antibodies to fibroblast growth factor receptor 2

HER3 antigen binding proteins binding to the beta-hairpin of HER3

Methods of treating vitiligo using PD-1 binding antibodies

Anti-HER2 antibodies and methods of use

Human PAC1 antibodies

ANTIBODIES THAT BIND CELL SURFACE GRP78 AND THEIR USE FOR DETECTION OF CANCER

Antibodies that bind interleukin-2 and uses thereof

AMYLOID-BETA BINDING PROTEINS

High affinity antibodies that neutralize enterotoxin B

Method of treating allergic asthma with antibodies to IL-6

CD48 antibodies and conjugates thereof

Methods of treating psoriasis using PD-1 binding antibodies

Humanized anti-C1s antibodies and methods of inhibiting C1s cleavage

COMPOSITIONS TO DISRUPT PROTEIN KINASE A ANCHORING AND USES THEREOF

Methods for controlling fucosylation levels in proteins

Bispecific T cell activating antigen binding molecules

ANTIBODIES BINDING TO PHOSPHORYLCHOLINE (PC) AND/OR PC CONJUGATES

NUCLEIC ACIDS ENCODING ANTIBODIES TO MATRIX METALLOPROTEINASE 9

ANTI-CD22 ANTIBODIES

Anti-IL-6/IL-6R antibodies and methods of use thereof

ANTI-CXCR3 ANTIBODIES AND METHODS OF USE THEREOF

Bispecific CXCR4-CD4 polypeptides with potent anti-HIV activity

Antibodies that bind to CCR6 and their uses

LIGANDS THAT BIND TGF-BETA RECEPTOR II

Anti-CD303 monoclonal antibodies

HLA-RESTRICTED EPITOPES ENCODED BY SOMATICALLY MUTATED GENES

Mechanically interlocking complexes

Anti-ANG2 antibody

Anti-plasmodium parasite antibodies

ENANTIOPURE HAPTENS FOR NICOTINE VACCINE DEVELOPMENT

Human cytomegalovirus neutralizing antibodies and use thereof

ANTI-WALL TEICHOIC ANTIBODIES AND CONJUGATES

Antibody-SN-38 immunoconjugates with a CL2A linker

Combination of a CD30XCD16 antibody with a PD-1 antagonist for therapy

Antibody specifically binding to ErbB3 and use thereof

ANTI-CEA ANTIBODIES

METHODS AND COMPOSITIONS TO TREAT AND DETECT MISFOLDED-SOD1 MEDIATED DISEASES

Single domain antibodies that bind to human CD20

Methods for treating obesity and nonalcoholic fatty liver disease or nonalcoholic steatohepatitis using glucagon receptor antagonistic antibodies

Anti-CD123 antibodies and conjugates and derivatives thereof

Constructs targeting AFP peptide/MHC complexes and uses thereof

ANTI-H7CR ANTIBODIES

Anti-human vista antibodies and use thereof

Humanized Antibodies To LIV-1 And Use Of Same To Treat Cancer

ANTI-IL-17A AND IL-17F CROSS REACTIVE ANTIBODY VARIANTS AND COMPOSITIONS COMPRISING AND METHODS OF MAKING AND USING SAME

Humanized anti-tau(pS422) antibodies and methods of use

Antibody-mediated neutralization of Chikungunya virus

Human immunodeficiency virus neutralizing antibodies and methods of use thereof

Polyomavirus neutralizing antibodies

CXCR4 binding molecules and methods of use thereof

Method of treating cancer with humanized anti-OX40 antibodies

Recombinant TNF ligand family member polypeptides with antibody binding domain and uses thereof

Anti-Flt-1 antibodies for treating duchenne muscular dystrophy

Anti-FLT-1 antibodies in treating bronchopulmonary dysplasia

ANTI-TIM3 ANTIBODIES AND METHODS OF USE

Stable and soluble antibodies inhibiting VEGF

Anti-netrin-1 antibody

Engineered antibody for inhibition of fibrosis

HIV-1 neutralizing antibodies and uses thereof (V3 antibodies)

Mast cell stabilizers for treatment of hypercytokinemia and viral infection

Disruption of the WAVE3 protein complex for suppression of invasion and metastasis

Anti-CD38 antibodies

HER3 specific monoclonal antibodies for diagnostic and therapeutic use

Antibodies and vaccines for use in treating ROR1 cancers and inhibiting metastasis

Cell line overexpressing human CD303 antigen

Anti-ICOS antibodies

ANTI-H7CR ANTIBODIES

Anti-TIGIT antibodies

Human antibodies that bind lymphocyte activation gene-3 (LAG-3), and uses thereof

Nucleic acids encoding agonistic antibodies that bind CD40

Monoclonal antibodies against amyloid beta protein and uses thereof

Antibodies targeting a galactan-based O-antigen of K. pneumoniae

Mast cell stabilizers for treatment of hypercytokinemia and viral infection

METHODS OF TREATING MENINGIOMA

Anti-transferrin receptor / anti-BACE1 multispecific antibodies and methods of use

COMBINATION THERAPY OF CANCER WITH ANTI-ENDOGLIN ANTIBODIES AND ANTI-VEGF AGENTS

Binding molecules to the human OX40 receptor

Fn14 binding proteins and uses thereof

Multivalent and multiepitopic antibodies having agonistic activity and methods of use

BINDING MEMBERS OF INTERLEUKIN-4 RECEPTOR ALPHA (IL4-Ra)

Therapeutic CD47 antibodies

Anti-Tim-3 antibodies

ANTI-NOTCH2 NRR ANTIBODIES

Anti-hepcidin antibodies and uses thereof

Anti-IL-25 antibodies and uses thereof

Antibodies targeting M-CSF

ANTAGONIST ANTIBODIES AGAINST GDF-8 AND USES THEREFOR

Nucleic acids encoding, and methods of producing, antibodies specific for transforming growth factor (TGF)-β

Broadly neutralizing human immunodeficiency virus type 1 (HIV-1) GP120-specific monoclonal antibody

Therapeutic use of specific ligand in MSRV associated diseases

Multispecific antibodies facilitating selective light chain pairing

TUMOR NECROSIS FACTOR-LIKE LIGAND 1A SPECIFIC ANTIBODIES AND COMPOSITIONS AND USES THEREOF

Methods of treating immune diseases by administering antibody polypeptides that specifically bind CD40L

ACTRIIB BINDING AGENTS AND USES THEREOF

Anti-PD-1 checkpoint inhibitor antibodies that block binding of PD-L1 to PD-1

Antibodies directed against programmed death-1 (PD-1)

Therapeutic CD47 antibodies

T cell receptors and immune therapy using the same

Anti-TNFα binding compounds and uses thereof

Anti-amyloid-beta antibodies

Anti-PAD4 antibody

HUMAN ANTIBODIES AGAINST TISSUE FACTOR AND METHODS OF USE THEREOF

Engineered antibodies and other Fc-domain containing molecules with enhanced agonism and effector functions

Anti-human interleukin-1 receptor accessory protein antibody and its use for treating cancer

Car-expressing cells against multiple tumor antigens and uses thereof

Anti-CLL-1 antibodies and immunoconjugates

Anti-CLL-1 antibodies and immunoconjugates

Polymeric Fc proteins and methods of screening to alter their functional characteristics

Modified-IgG antibodies that bind transforming growth factor-β1 with high affinity, avidity and specificity

Angiopoietin-like 4 antibodies and methods of use

Anti-glucosaminidase passive immunization for infections

Compositions Using Antibodies Directed to GPNMB and Uses Thereof

Antagonists of IL-6 to raise albumin and/or lower CRP

PLASMA KALLIKREIN BINDING PROTEINS

PLASMA KALLIKREIN BINDING PROTEINS

PLASMA KALLIKREIN BINDING PROTEINS

Methods and compositions related to single chain antibody fragments that bind to tumor-associated glycoprotein 72 (TAG-72)

Methods of preparation of conjugates

Treatment of post-prandial hyperinsulinemia and hypoglycemia after bariatric surgery

Antibody targeting osteoclast-related protein Siglec-15

Anti-HCTLA-4 antibodies

Disrupting FC receptor engagement on macrophages enhances efficacy of anti-SIRPα antibody therapy

Anti-GPRC5D antibodies, bispecific antigen binding molecules that bind GPRC5D and CD3, and uses thereof

EPITOPES OF IL-17A AND IL-17F AND ANTIBODIES SPECIFIC THERETO

Methods of treating inflammation with IL-17A/F and IL-23P19 bispecific antibodies

Anti-IL-33 antibodies, compositions, methods and uses thereof

Antibody molecules and uses thereof

Anti-infective binding proteins that bind AIP2

Engineered polypeptides and uses thereof

Monovalent antigen binding proteins

Polynucleotides encoding bispecific EGFR/IGF-IR binding molecules

RADIO-LABELLED ANTIBODY FRAGMENTS FOR USE IN THE PROGNOSIS, DIAGNOSIS OF CANCER AS WELL AS FOR THE PREDICTION OF CANCER THERAPY RESPONSE

Antibodies against the MUC1-C/extracellular domain (MUC1-C/ECD)

Methods of delivering DLL3 antibody drug conjugates

Methods of making DLL3 antibody drug conjugates

Anti-ErbB3 antibodies and uses thereof

Anti-EGFR Antibodies and Uses Thereof

Methods of identifying bacteria comprising binding polypeptides

Antibody binding to TFPI and composition comprising the same

Anti-ERBB3 antibodies

COMPOSITIONS AND METHODS FOR THE DETECTION DIAGNOSIS AND THERAPY OF HEMATOLOGICAL MALIGNANCIES

CD73 BLOCKADE

CX3CR1-binding polypeptides comprising immunoglobulin single variable domains

NOVEL BINDING PROTEINS COMPRISING A UBIQUITIN MUTEIN AND ANTIBODIES OR ANTIBODY FRAGMENTS

Anti-PD-1 antibodies

ICOS BINDING PROTEINS

Human monoclonal antibody specific for the F protein of respiratory syncytial virus (RSV)

Synthetic single domain antibody

EGFR binding proteins

PCSK9 antibody, and pharmaceutical composition and use thereof

Reversal binding agents for anti-factor XI/XIa antibodies and uses thereof

NOVEL ANTI-FIBROBLAST ACTIVATION PROTEIN (FAP) BINDING AGENTS AND USES THEREOF

Bispecific anti-HER2 antibody

Anti-CEACAM5 antibodies and uses thereof

Monoclonal antibodies against HER2 epitope

Antigen binding complex having agonistic activity and methods of use

Chemokine receptor binding polypeptides

Bispecific binding proteins and uses thereof

Anti-pre-BCR antagonists and methods

Antibodies that target human protein tyrosine phosphatase-beta (HPTP-beta) and methods of use thereof to treat ocular conditions

Monoclonal antibodies to progastrin and their uses

Isolated host cells expressing anti-IL-6 antibodies

TRANSTHYRETIN ANTIBODIES AND USES THEREOF

Methods for treating ischemic stroke using chimeric and humanized anti-histone antibodies

Anticancer agents or antimetastatic agents using FSTL1 and combination drug thereof

Methods for treating back or neck pain caused by NGF using a therapeutic agent comprising REN-1820, ALE-0540 and capsaicin

Domain-exchanged antibody

Method for obtaining high-yield, stable expression cell clones and antibody molecules obtained thereby

TARGETING CONSTRUCTS FOR DELIVERY OF PAYLOADS

Conjugated anti-CD38 antibodies

Human neutralizing antibodies binding to influenza neuraminidase

Multivalent molecules comprising DR5-binding domains

Methods for the treatment of interleukin-6 receptor-related diseases and disorders

Antibody Therapeutics That Bind CD123

Monoclonal Antibodies for Enhancing or Inhibiting Insulin-Like Growth Factor 1 (IGF-1)

ANTI CEACAM1 ANTIBODIES AND METHODS OF USING SAME

Antibodies against TIM3 and uses thereof

FcRn antibodies and methods of use thereof

COMPOSITIONS AND METHODS FOR GROWTH FACTOR MODULATION

Antibodies specific for hyperphosphorylated tau and methods of use

Humanized antibodies that recognize alpha-synuclein

A Combination of Two or More Anti-C5 Antibodies and Methods of Use

Anti-wall teichoic antibodies and conjugates

Anti-Zika virus antibodies and methods of use

Anti-DLL3 antibody drug conjugates and methods of use

Anti-Ly6E antibodies and immunoconjugates and methods of use

Antibodies that bind human C6 and uses thereof

Optimized antibodies that target CD19

Anti-CD73 antibodies

Anti-CLL-1 antibodies and immunoconjugates

ANTI-ROR1 ANTIBODIES

Antibodies against notch 3

Methods of treating atypical hemolytic uremic syndrome with anti-C5 antibodies

Antibody molecules and peptide delivery systems for use in alzheimer's disease and related disorders

POLYPEPTIDES

Phage-displayed single-chain variable fragment library

Diagnostic assays and kits for detection of folate receptor 1

FRIZZLED 2 AS A TARGET FOR THERAPEUTIC ANTIBODIES IN THE TREATMENT OF CANCER

PLASMA KALLIKREIN BINDING PROTEINS

PLASMA KALLIKREIN BINDING PROTEINS

PLASMA KALLIKREIN BINDING PROTEINS

Anti-MERTK agonistic antibodies and uses thereof

Cytotoxic benzodiazepine derivatives

ANTI-MESOTHELIN ANTIBODIES AND USES THEREOF

Humanized anti-trop-2 monoclonal antibodies and uses thereof

Anti-transferrin receptor antibodies and methods of use

Antibodies against glucocorticoid-induced tumor necrosis factor receptor (GITR) and uses thereof

Methods of treating cancer using anti human interleukin-1 receptor accessory protein (IL1 RAP) antibodies

Oncostatin M receptor antigen binding proteins

Anti-CXCR4 antibodies and antibody-drug conjugates

Methods and compositions related to modulators of eukaryotic cells

PD-L1-specific antibodies and methods of using the same

Anti-PD-L1 antibodies

Monoclonal antibodies targeting killer immunoglobulin-like receptor (KIR) family signaling

Interferon alpha and omega antibody antagonists

Methods of neutralizing C5 with anti-C5 antibodies

Antibodies to α-synuclein and uses thereof

Human Anti-Tau Antibodies

AGLYCOSYLATED ANTI-Bb ANTIBODIES AND USES THEREOF

Methods for producing optimised therapeutic molecules

Fusion proteins of natural human protein fragments to create orderly multimerized immunoglobulin Fc compositions

BLOOD BRAIN BARRIER RECEPTOR ANTIBODIES AND METHODS OF USE

Antibody-urease conjugates for therapeutic purposes

BISPECIFIC ANTIBODIES AGAINST HER2 AND CD3

Mice expressing a limited immunoglobulin light chain repertoire

NOVEL ANTI-FIBROBLAST ACTIVATION PROTEIN (FAP) ANTIBODIES AND USES DERIVED THEREOF

BISPECIFIC ANTIBODIES AGAINST HER2

Binding members for human c-MAF

Bispecific tetravalent antibodies and methods of making and using thereof

Humanized anti-CD134 (OX40) antibodies and uses thereof

Anti-CD276 polypeptides, proteins, and chimeric antigen receptors

Hyperglycosylated binding polypeptides

Antibodies to CD70

High affinity antibody antagonists of interleukin-13 receptor alpha 1

Antibodies directed against CD4 for the treatment and functional cure of HIV

Single chain variable fragment CD3 binding proteins